Nano-Bio-Chip sensor platform for examination of oral exfoliative cytology

Cancer Prevention Research

Volumn 3, Issue 4, 2010, Pages 518-528

  Weigum, Shannon E ^a   Floriano, Pierre N ^a   Redding, Spencer W ^d   Yeh, Chih Ko ^d   Westbrook, Stephen D ^d   McGuff, H Stan ^e   Lin, Alan ^d   Miller, Frank R ^d   Villarreal, Fred ^d   Rowan, Stephanie D ^d   Vigneswaran, Nadarajah ^b   Williams, Michelle D ^c   McDevitt, John T ^a  

^a RICE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; BIOCHEMISTRY; BIOCHIP; BIOSENSOR; CARCINOGENESIS; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; CYTOPLASM; EPITHELIUM; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MOUTH CANCER; MOUTH EXAMINATION; MOUTH LESION; MOUTH MUCOSA; MOUTH TUMOR; NANOSENSOR; NUCLEAR SIZE; PILOT STUDY; PRECANCER; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AREA UNDER CURVE; CELL NUCLEUS; CYTODIAGNOSIS; CYTOLOGICAL TECHNIQUES; CYTOPLASM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NANOTECHNOLOGY; PILOT PROJECTS; PRECANCEROUS CONDITIONS; RECEPTOR, EPIDERMAL GROWTH FACTOR; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77950843984     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0139     Document Type: Article

References (38)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. American Cancer Society. Cancer facts and figures. Atlanta (GA): American Cancer Society; 2008.
3. Seiwert TY, Cohen EE. State-of -the-art management of locally advanced head and neck cancer. Br J Cancer 2005;92:1341-1348
4. Ries LAG MD, Krapcho M, Mariotto A, et al. SEER cancer statistics review 1975-2004. Bethesda (MD): National Cancer Institute.
5. Lee JJ, Hong WK, Hittelman WN, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 2000;6:1702-1710
6. Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from the Netherlands. Oral Oncol 1998;34:270-275
7. Speight PM, Farthing PM, Bouquot JE. The pathology of oral cancer and precancer. Curr Diag Pathol 1996;3:165-176
8. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003;14:47-62.
9. van der Waal I, Schepman KP, van der Meij EH, Smeele LE. Oral leukoplakia: a clinicopathological review. Oral Oncol 1997;33:291-301.
10. Karabulut A, Reibel J, Therkildsen MH, Praetorius F, Nielsen HW, Dabelsteen E. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 1995;24:198-200.
11. Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80:188-191
12. Sugerman PB, Savage NW. Exfoliative cytology in clinical oral pathology. Aust Dent J 1996;41:71-74
13. Ogden GR, Cowpe JG, Green M. Cytobrush and wooden spatula for oral exfoliative cytology. A comparison. Acta Cytol 1992;36: 706-710
14. Ogden GR. The future role for oral exfoliative cytology-bleak or bright? Oral Oncol 1997;33:2-4.
15. Driemel O, Dahse R, Hakim SG, et al. Laminin-5 immunocytochemistry: a new tool for identifying dysplastic cells in oral brush biopsies. Cytopathology 2007;18:348-355
16. Spafford MF, Koch WM, Reed AL, et al. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res 2001;7:607-612
17. Schwartz JL, Panda S, Beam C, Bach LE, Adami GR. RNA from brush oral cytology to measure squamous cell carcinoma gene expression. J Oral Pathol Med 2008;37:70-77
18. Veltman JA, Hopman AH, Bot FJ, Ramaekers FC, Manni JJ. Detection of chromosomal aberrations in cytologic brush specimens from head and neck squamous cell carcinoma. Cancer 1997;81: 309-314
19. Sciubba JJ, U.S. Collaborative OralCDx Study Group. Improving detection of precancerous and cancerous oral lesions. Computerassisted analysis of the oral brush biopsy. J Am Dent Assoc 1999; 130:1445-1457
20. Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 2008; 44:10-22.
21. Poate TW, Buchanan JA, Hodgson TA, et al. An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit. Oral Oncol 2004;40:829-834
22. Scheifele C, Schmidt-Westhausen AM, Dietrich T, Reichart PA. The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases. Oral Oncol 2004;40:824-828
23. Ali MF, Kirby R, Goodey AP, et al. DNA hybridization and discrimination of single-nucleotide mismatches using chip-based microbead arrays. Anal Chem 2003;75:4732-4739
24. Christodoulides N, Floriano PN, Miller CS, et al. Lab-on-a-chip methods for point-of -care measurements of salivary biomarkers of periodontitis. Oral-Based Diagnostics 2007:411-428
25. Rodriguez WR, Christodoulides N, Floriano PN, et al. A microchip CD4 counting method for HIV monitoring in resource-poor settings. Plos Medicine 2005;2:663-672
26. Floriano PN, Christodoulides N, Romanovicz DK, et al. Membranebased on-line optical analysis system for rapid detection of bacteria and spores. Biosens Bioelectron 2005;20:2079-2088
27. Weigum SE, Floriano PN, Christodoulides N, McDevitt JT. Cellbased sensor for analysis of EGFR biomarker expression in oral cancer. Lab Chip 2007;7:995-1003.
28. Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993;53:3579-3584
29. Shin DM, Ro JY, Hong WK, Hittelman WN. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994;54:3153-3159
30. Rasband WS. Image J. Bethesda (MD): U.S. National Institutes of Health; 19997-22006
31. Carpenter AE, Jones TR, Lamprecht MR, et al. CellProfiler: image analysis sof tware for identifying and quantifying cell phenotypes. Genome Biol 2006;7:R100.
32. Pektas ZO, Keskin A, Gunhan O, Karslioglu Y. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements. J Oral Maxillof ac Surg 2006;64:628-635
33. Ramaesh T, Mendis BR, Ratnatunga N, Thattil RO. Cytomorphometric analysis of squames obtained from normal oral mucosa and lesions of oral leukoplakia and squamous cell carcinoma. J Oral Pathol Med 1998;27:83-86
34. Cowpe JG, Longmore RB, Green MW. Quantitative exfoliative cytology of abnormal oral mucosal smears. J R Soc Med 1988;81:509-513
35. Anuradha C, Reddy BV, Nandan SR, Kumar SR. Oral lichen planus. A review. N Y State Dent J 2008;74:66-68
36. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996;49:1373-1379
37. Lane PM, Gilhuly T, Whitehead P, et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt 2006; 11:024006.
38. Ram S, Siar CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillof ac Surg 2005;34:521-527